Company: REE
Filing Date: 2025-03-19
Form Type: 424B5
Source: 0001213900-25-024847
Chunk: 7

Company: REE Automotive Ltd.
Filing Date: 2025-03-19
Form: 424B5
Chunk 7
---
 $4.25 per Ordinary Share                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Use of proceeds                                                   |     | We intend to use the net proceeds we receive from the sale of Ordinary Shares for general working capital. Please read “Use of Proceeds” in this prospectus supplement for more information.                                                                                                                                                                                                                                                            |
| Exchange listing                                                  |     | Our Ordinary Shares are listed on Nasdaq under the symbol “REE.”                                                                                                                                                                                                                                                                                                                                                                                        |
| Risk factors                                                      |     | Investing in our securities involves risks. Please read “Risk Factors” beginning on page S-3 of this prospectus supplement, page 4 of the accompanying prospectus and in the documents that we have incorporated by reference, as well as the other cautionary statements throughout this prospectus supplement and the accompanying prospectus, for a discussion of factors you should carefully consider before deciding to invest in our securities. |

Unless otherwise indicated, the number of Ordinary Shares referenced in this prospectus supplement is based on 18,927,953 Ordinary Shares outstanding as of September 30, 2024, and excludes as of such date:

| ● | 3,834,246 Ordinary Shares issuable upon the exercise of outstanding options, at a weighted average exercise price of $4.55 per Ordinary Share;           |
| ● | 1,870,061 Ordinary Shares issuable upon the vesting of restricted share units, or RSUs, outstanding;                                                     |
| ● | 382,794 Ordinary Shares reserved for future awards under our equity incentive plans;                                                                     |
| ● | 1,702,372 Ordinary Shares issuable upon the exercise of outstanding warrants, at a weighted average exercise price of $4.52 per Ordinary Share;          |
| ● | 3,639,893 Ordinary Shares issuable upon the exercise of outstanding pre funded warrants, prices from $0.001 per Ordinary Share; and                      |
| ● | 2,296,963 Ordinary Shares issuable upon the conversion of outstanding convertible promissory notes, convertible at a price of $4.122 per Ordinary Share. |

Unless otherwise indicated, all information in this prospectus assumes no exercise of the outstanding options described above.

<div align='center'>S-2

RISK FACTORS</div>

An investment in our securities involves risks. You should carefully consider the risks described below together with the risk factors described in reports we file with the SEC and incorporated by reference into the accompanying prospectus, as well as all of the other information in, and incorporated by reference into,